Drug Price Trends for NDC 00904-7496

Average Pharmacy Cost for 00904-7496

Drug Name	NDC	Price/Unit ($)	Unit	Date
TRAMADOL HCL 50 MG TABLET	00904-7496-61	0.02368	EACH	2025-12-17
TRAMADOL HCL 50 MG TABLET	00904-7496-61	0.02407	EACH	2025-11-19
TRAMADOL HCL 50 MG TABLET	00904-7496-61	0.02435	EACH	2025-10-22
TRAMADOL HCL 50 MG TABLET	00904-7496-61	0.02510	EACH	2025-09-17

Best Wholesale Price for NDC 00904-7496

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type

00904-7496 Market Analysis and Financial Projection

Last updated: July 27, 2025

Market Analysis and Price Projections for Drug NDC: 00904-7496 (Tramadol Hydrochloride)

Tramadol hydrochloride (NDC: 00904-7496) is an opioid analgesic medication used for managing moderate to moderately severe pain in adults. As a generic drug manufactured by Major Pharmaceuticals, it plays a significant role in pain management strategies. This article provides a comprehensive market analysis and price projections for this specific drug, offering valuable insights for healthcare professionals, industry analysts, and stakeholders.

Current Market Landscape

Tramadol hydrochloride is widely used in the United States for pain management. As a generic medication, it offers a more affordable alternative to brand-name opioid analgesics. The drug is available in tablet form, with the NDC 00904-7496 specifically referring to Major Pharmaceuticals' version[1][4].

Factors Influencing Market Dynamics

Several factors are shaping the market dynamics for Tramadol hydrochloride:

1. Opioid Crisis and Regulatory Environment

The ongoing opioid crisis in the United States has led to increased scrutiny and regulation of opioid medications. This has impacted prescribing patterns and may influence the demand for Tramadol hydrochloride. Regulatory changes and guidelines for opioid prescribing could significantly affect the market for this drug.

2. Aging Population

The growing elderly population is likely to increase the demand for pain management medications. As people age, they often experience more chronic pain conditions, potentially driving up the use of drugs like Tramadol hydrochloride.

3. Alternative Pain Management Strategies

The push for non-opioid pain management alternatives may impact the market for Tramadol hydrochloride. Healthcare providers may increasingly explore other options before prescribing opioids, potentially affecting demand.

4. Generic Competition

As a generic medication, Tramadol hydrochloride faces competition from other manufacturers. This competition typically helps keep prices lower but may also impact market share for specific NDCs.

Price Projections

Projecting drug prices involves considering multiple factors, including production costs, market demand, and the competitive landscape. For Tramadol hydrochloride (NDC: 00904-7496), the following trends are likely to influence its pricing:

1. Generic Drug Pricing Trends

As a generic drug, Tramadol hydrochloride typically offers significant cost savings compared to brand-name alternatives. This price advantage is expected to continue, making it an attractive option for both patients and healthcare providers[3].

2. Market Competition

The presence of other generic versions of Tramadol may exert downward pressure on prices. However, established manufacturers like Major Pharmaceuticals may maintain a pricing edge due to their reputation and supply chain efficiencies.

3. Production Costs

Any fluctuations in raw material costs or changes in manufacturing processes could impact the pricing of Tramadol hydrochloride. However, as an established generic drug, significant price volatility is less likely.

4. Healthcare Policies

Changes in healthcare policies, such as adjustments to Medicare or Medicaid reimbursement rates, could influence the pricing strategy for Tramadol hydrochloride[2].

Future Market Outlook

The future market for Tramadol hydrochloride (NDC: 00904-7496) is likely to be influenced by several factors:

1. Continued Demand

Despite the push for alternative pain management strategies, opioid medications like Tramadol are likely to remain an important part of pain management protocols, especially for moderate to severe pain.

2. Regulatory Landscape

Ongoing changes in opioid regulations and prescribing guidelines will continue to shape the market for Tramadol hydrochloride. Manufacturers and healthcare providers will need to stay abreast of these changes.

3. Generic Market Dynamics

The generic drug market is expected to continue growing, which could lead to further price competition among Tramadol manufacturers. This could potentially result in lower prices for consumers but may also impact profit margins for manufacturers.

4. Technological Advancements

Advancements in drug delivery systems or the development of new pain management technologies could impact the market for traditional opioid medications like Tramadol hydrochloride.

Conclusion

The market for Tramadol hydrochloride (NDC: 00904-7496) is expected to remain stable with moderate growth potential. While the opioid crisis has led to increased scrutiny of these medications, Tramadol's position as a less potent opioid may work in its favor. Price projections suggest relative stability, with potential for slight decreases due to generic competition and regulatory pressures.

Healthcare providers, payers, and industry stakeholders should continue to monitor regulatory changes, prescribing trends, and market dynamics to make informed decisions regarding the use and procurement of Tramadol hydrochloride. As with all opioid medications, balancing effective pain management with responsible prescribing practices will remain crucial in the coming years.

"We predict continued moderate growth of 4-6% in overall drug expenditures (across the entire U.S. market). We expect the clinic sector to continue to experience high (11-13%) growth in drug spending in 2019. Finally, for nonfederal hospitals we anticipate growth in the range of 3-5%."[3]

This projection from a 2019 study suggests a trend of moderate growth in drug expenditures, which may apply to medications like Tramadol hydrochloride as well. However, it's important to note that individual drug prices may vary based on specific market factors and regulatory changes.

Key Takeaways

1. Tramadol hydrochloride (NDC: 00904-7496) remains an important medication for moderate to moderately severe pain management.
2. The opioid crisis and resulting regulatory changes continue to shape the market for opioid medications.
3. As a generic drug, Tramadol hydrochloride offers cost advantages, but faces competition from other manufacturers.
4. Future pricing is expected to remain relatively stable, with potential for slight decreases due to market competition and regulatory pressures.
5. Healthcare providers and stakeholders should stay informed about regulatory changes and prescribing guidelines for opioid medications.

FAQs

1. Q: How might the ongoing opioid crisis affect the market for Tramadol hydrochloride? A: The opioid crisis has led to increased scrutiny and regulation of opioid medications. While this may result in more cautious prescribing practices, Tramadol's position as a less potent opioid could potentially work in its favor compared to stronger opioids.

2. Q: What factors could lead to price changes for Tramadol hydrochloride? A: Factors that could influence pricing include changes in production costs, increased generic competition, regulatory changes, and shifts in healthcare policies or reimbursement rates.

3. Q: How does the generic status of Tramadol hydrochloride impact its market position? A: As a generic medication, Tramadol hydrochloride typically offers cost advantages over brand-name alternatives, making it an attractive option for patients and healthcare providers. However, it also faces competition from other generic manufacturers.

4. Q: Are there any upcoming regulatory changes that could impact the market for Tramadol hydrochloride? A: While specific regulatory changes can be difficult to predict, ongoing efforts to address the opioid crisis may lead to new guidelines or restrictions on opioid prescribing, which could impact the market for Tramadol hydrochloride.

5. Q: How might advancements in pain management technologies affect the demand for Tramadol hydrochloride? A: New pain management technologies or alternative treatments could potentially reduce reliance on opioid medications. However, Tramadol is likely to remain an important option for managing moderate to moderately severe pain in the foreseeable future.

1: https://www.findacode.com/ndc/labelers/Major_Pharmaceuticals 2: https://aspe.hhs.gov/sites/default/files/documents/3e8abec86039ac0ed674a8c5fac492e3/price-change-over-time-brief.pdf 3: https://pubmed.ncbi.nlm.nih.gov/31199861/ 4: https://ndclist.com/ndc/0904-7496/package/0904-7496-61